
Full profile: /officials/K000367
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
26 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Currently in
The legislation would require pharmaceutical companies to justify and potentially negotiate drug prices with Medicare, aiming to make prescription medications more affordable for seniors and other patients. It would give the federal government more authority to review whether drug prices are reasonable compared to their actual development costs and effectiveness. This could lower out-of-pocket costs for people taking expensive medications, though it might also affect how quickly new drugs reach the market.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.